Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pheochromocytoma and paraganglioma: molecular testing and personalized medicine.

Current opinion in oncology - 1 Jan 2016

Burnichon Nelly, Buffet Alexandre, Gimenez-Roqueplo Anne-Paule

Abstract excerpt

PURPOSE OF REVIEW: Pheochromocytomas and paragangliomas (PPGLs) are rare tumours, strongly associated with inherited susceptibility gene mutations, and presenting limited therapeutic options for patients with metastatic disease. This review discusses the recent developments in the characterization of PPGL genetic heterogeneity and associated tumorigenesis pathways, together with their potential clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal and Paraganglionic Tumors
Share to Adrenal Gland Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to High-Throughput Nucleotide Sequencing

Share to Mutation

Share to Paraganglioma

Share to Pheochromocytoma

Share to Precision Medicine

Source

Identifiers

PMID: 26599293
DOI: 10.1097/CCO.0000000000000249

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pheochromocytoma and paraganglioma: molecular testing and personalized medicine.PMID 26599293Read ↗

Genetic bases of pheochromocytoma and paraganglioma.Semantic proximity Read ↗

Clinical and molecular markers guide the genetics of pheochromocytoma and paraganglioma.Semantic proximity Read ↗

The Molecular Classification of Pheochromocytomas and Paragangliomas: Discovering the Genomic and Immune Landscape of Metastatic DiseaseSemantic proximity Read ↗

Rethinking pheochromocytomas and paragangliomas from a genomic perspective.Semantic proximity Read ↗

The Management of Phaeochromocytomas and Paragangliomas in the Era of Precision Medicine: Where Are We Now? Evidence-Based Systemic Treatment Options and Future Cluster Oriented PerspectivesSemantic proximity Read ↗

Update on the genetics of paragangliomas.Semantic proximity Read ↗

Insights into the genetic landscape of pheochromocytomas and paragangliomas in a Brazilian cohort.Semantic proximity Read ↗

Pheochromocytoma: When to search a germline defect?Semantic proximity Read ↗

Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas.Semantic proximity Read ↗

Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research ApproachesSemantic proximity Read ↗

Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paragangliomaSemantic proximity Read ↗

Novel Gene Variants in a Nationwide Cohort of Patients with Pheochromocytoma and Paraganglioma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.